ITGAM and neoplasm: In contrast to previous studies that suggested BM-derived CD11b+GR-1+ IMCs from tumor-free mice lack immunosuppressive activity [8], this is the first study to definitively document that CD11b+GR-1+ IMCs isolated from the BM of non tumor-bearing mice have comparable ability to suppress T-cell proliferation as MDSCs from tumor-bearing mice.